 Recombinant Fusion Proteins
"Recombinant Fusion Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Recombinant proteins produced by the GENETIC TRANSLATION of fused genes formed by the combination of NUCLEIC ACID REGULATORY SEQUENCES of one or more genes with the protein coding sequences of one or more genes.
| Descriptor ID |
D011993
|
| MeSH Number(s) |
D12.776.828.300
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Recombinant Fusion Proteins".
Below are MeSH descriptors whose meaning is more specific than "Recombinant Fusion Proteins".
This graph shows the total number of publications written about "Recombinant Fusion Proteins" by people in this website by year, and whether "Recombinant Fusion Proteins" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1987 | 0 | 2 | 2 | | 1988 | 3 | 2 | 5 | | 1989 | 1 | 3 | 4 | | 1990 | 0 | 5 | 5 | | 1991 | 1 | 7 | 8 | | 1992 | 2 | 13 | 15 | | 1993 | 3 | 10 | 13 | | 1994 | 2 | 17 | 19 | | 1995 | 0 | 14 | 14 | | 1996 | 3 | 13 | 16 | | 1997 | 2 | 19 | 21 | | 1998 | 1 | 16 | 17 | | 1999 | 2 | 13 | 15 | | 2000 | 2 | 23 | 25 | | 2001 | 4 | 32 | 36 | | 2002 | 1 | 31 | 32 | | 2003 | 7 | 19 | 26 | | 2004 | 7 | 22 | 29 | | 2005 | 6 | 16 | 22 | | 2006 | 1 | 18 | 19 | | 2007 | 3 | 16 | 19 | | 2008 | 3 | 20 | 23 | | 2009 | 6 | 15 | 21 | | 2010 | 5 | 26 | 31 | | 2011 | 7 | 14 | 21 | | 2012 | 7 | 10 | 17 | | 2013 | 11 | 8 | 19 | | 2014 | 5 | 8 | 13 | | 2015 | 9 | 10 | 19 | | 2016 | 6 | 12 | 18 | | 2017 | 5 | 6 | 11 | | 2018 | 0 | 2 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Recombinant Fusion Proteins" by people in Profiles.
-
Hua DA, Casella AM, Berrocal MH, Han D, Alshareef RA, Quiroz-Mercado H, Arevalo JF, Chhablani J. OUTCOMES OF ANTI-VEGF THERAPY IN CHOROIDAL NEOVASCULARIZATION AFTER MACULAR SURGERY. Retin Cases Brief Rep. 2018 Fall; 12(4):359-366.
-
Youmans DT, Schmidt JC, Cech TR. Live-cell imaging reveals the dynamics of PRC2 and recruitment to chromatin by SUZ12-associated subunits. Genes Dev. 2018 06 01; 32(11-12):794-805.
-
Kumar A, Katz LS, Schulz AM, Kim M, Honig LB, Li L, Davenport B, Homann D, Garcia-Ocaña A, Herman MA, Haynes CM, Chipuk JE, Scott DK. Activation of Nrf2 Is Required for Normal and ChREBPa-Augmented Glucose-Stimulated ß-Cell Proliferation. Diabetes. 2018 08; 67(8):1561-1575.
-
King TH, Shanley CA, Guo Z, Bellgrau D, Rodell T, Furney S, Henao-Tamayo M, Orme IM. GI-19007, a Novel Saccharomyces cerevisiae-Based Therapeutic Vaccine against Tuberculosis. Clin Vaccine Immunol. 2017 Dec; 24(12).
-
Jimeno A, Gordon M, Chugh R, Messersmith W, Mendelson D, Dupont J, Stagg R, Kapoun AM, Xu L, Uttamsingh S, Brachmann RK, Smith DC. A First-in-Human Phase I Study of the Anticancer Stem Cell Agent Ipafricept (OMP-54F28), a Decoy Receptor for Wnt Ligands, in Patients with Advanced Solid Tumors. Clin Cancer Res. 2017 Dec 15; 23(24):7490-7497.
-
Falconer IB, Mant CT, McKnight CJ, Vugmeyster L, Hodges R. Optimized purification of a fusion protein by reversed-phase high performance liquid chromatography informed by the linear solvent strength model. J Chromatogr A. 2017 Oct 27; 1521:44-52.
-
Nowak KL, Hung A, Ikizler TA, Farmer-Bailey H, Salas-Cruz N, Sarkar S, Hoofnagle A, You Z, Chonchol M. Interleukin-1 inhibition, chronic kidney disease-mineral and bone disorder, and physical function?. Clin Nephrol. 2017 Sep; 88(9):132-143.
-
Sasse SK, Kadiyala V, Danhorn T, Panettieri RA, Phang TL, Gerber AN. Glucocorticoid Receptor ChIP-Seq Identifies PLCD1 as a KLF15 Target that Represses Airway Smooth Muscle Hypertrophy. Am J Respir Cell Mol Biol. 2017 08; 57(2):226-237.
-
Walker AJ, Majzner RG, Zhang L, Wanhainen K, Long AH, Nguyen SM, Lopomo P, Vigny M, Fry TJ, Orentas RJ, Mackall CL. Tumor Antigen and Receptor Densities Regulate Efficacy of a Chimeric Antigen Receptor Targeting Anaplastic Lymphoma Kinase. Mol Ther. 2017 Sep 06; 25(9):2189-2201.
-
Chen Y, Anastassiadis K, Kranz A, Stewart AF, Arndt K, Waskow C, Yokoyama A, Jones K, Neff T, Lee Y, Ernst P. MLL2, Not MLL1, Plays a Major Role in Sustaining MLL-Rearranged Acute Myeloid Leukemia. Cancer Cell. 2017 06 12; 31(6):755-770.e6.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|